BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 29874641)

  • 1. Adenomyosis and Endometrial Cancer: Literature Review.
    Habiba M; Pluchino N; Petignat P; Bianchi P; Brosens IA; Benagiano G
    Gynecol Obstet Invest; 2018; 83(4):313-328. PubMed ID: 29874641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases.
    Lu B; Chen Q; Zhang X; Cheng L
    Diagn Pathol; 2016 Jun; 11(1):46. PubMed ID: 27260518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of 30 patients with atypical glandular hyperplasia or malignant transformation in foci of adenomyosis].
    Liu YT; Wang S; Shi HH; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2020 Jul; 55(7):471-475. PubMed ID: 32842251
    [No Abstract]   [Full Text] [Related]  

  • 4. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.
    Liu X; Shen M; Qi Q; Zhang H; Guo SW
    Hum Reprod; 2016 Apr; 31(4):734-49. PubMed ID: 26908845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenomyosis As a Confounder to Accurate Endometrial Cancer Staging.
    Khalifa MA; Atri M; Klein ME; Ghatak S; Murugan P
    Semin Ultrasound CT MR; 2019 Aug; 40(4):358-363. PubMed ID: 31375175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms-Review.
    Szubert M; Kozirog E; Wilczynski J
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical analysis of proliferative activity of endometrial and myometrial cell populations in focal and stromal adenomyosis.
    Nepomnyashchikh LM; Lushnikova EL; Molodykh OP; Pichigina AK
    Bull Exp Biol Med; 2013 Aug; 155(4):512-7. PubMed ID: 24143380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
    Matsuo K; Cahoon SS; Gualtieri M; Scannell CA; Jung CE; Takano T; Paulson RJ; Muderspach LI; Roman LD
    Ann Surg Oncol; 2014 Dec; 21(13):4246-55. PubMed ID: 25001096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grade 2 endometrioid adenocarcinoma arising from adenomyosis of the uterus: report of a case.
    Kazandi M; Zeybek B; Terek MC; Zekioglu O; Ozdemir N; Oztekin K
    Eur J Gynaecol Oncol; 2010; 31(6):719-21. PubMed ID: 21319528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis.
    Benagiano G; Brosens I; Habiba M
    Hum Reprod Update; 2014; 20(3):386-402. PubMed ID: 24140719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant changes in adenomyosis in patients with endometrial adenocarcinoma: A case series.
    Mao X; Zheng W; Mao W
    Medicine (Baltimore); 2017 Oct; 96(43):e8336. PubMed ID: 29069006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression and functionality of stromal caveolin 1 in human adenomyosis.
    Zhao L; Zhou S; Zou L; Zhao X
    Hum Reprod; 2013 May; 28(5):1324-38. PubMed ID: 23442759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant changes in adenomyosis in patients with endometrioid adenocarcinoma.
    Kucera E; Hejda V; Dankovcik R; Valha P; Dudas M; Feyereisl J
    Eur J Gynaecol Oncol; 2011; 32(2):182-4. PubMed ID: 21614909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis.
    Chen YJ; Li HY; Huang CH; Twu NF; Yen MS; Wang PH; Chou TY; Liu YN; Chao KC; Yang MH
    J Pathol; 2010 Nov; 222(3):261-70. PubMed ID: 20814901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology and Pathogenesis of Adenomyosis.
    Antero MF; Ayhan A; Segars J; Shih IM
    Semin Reprod Med; 2020 May; 38(2-03):108-118. PubMed ID: 33080632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterising the immune cell phenotype of ectopic adenomyosis lesions compared with eutopic endometrium: A systematic review.
    Maclean A; Barzilova V; Patel S; Bates F; Hapangama DK
    J Reprod Immunol; 2023 Jun; 157():103925. PubMed ID: 36870297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
    Nascimento AF; Hirsch MS; Cviko A; Quade BJ; Nucci MR
    Mod Pathol; 2003 Jan; 16(1):22-7. PubMed ID: 12527709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Good outcome of endometrial cancer patients coexisting with adenomyosis is a result of their associated favorable clinico-pathological parameters.
    Chou FW; Lee NR; Wang PH
    Taiwan J Obstet Gynecol; 2023 Nov; 62(6):795-796. PubMed ID: 38008494
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological changes associated with adenomyosis: a systematic review.
    Bourdon M; Santulli P; Jeljeli M; Vannuccini S; Marcellin L; Doridot L; Petraglia F; Batteux F; Chapron C
    Hum Reprod Update; 2021 Jan; 27(1):108-129. PubMed ID: 33099635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and significance of bcl-2, bax and ER in foci of adenomyosis].
    Li B; Wang L; Fan Y; Wang J; Guo D
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):923-7. PubMed ID: 23324193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.